Inscription Capital LLC Makes New Investment in UnitedHealth Group Incorporated (NYSE:UNH)

Inscription Capital LLC acquired a new position in UnitedHealth Group Incorporated (NYSE:UNH) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 6,087 shares of the healthcare conglomerate’s stock, valued at approximately $3,011,000.

A number of other hedge funds have also recently bought and sold shares of UNH. Financial Management Professionals Inc. boosted its stake in shares of UnitedHealth Group by 0.8% in the 1st quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate’s stock valued at $1,165,000 after purchasing an additional 17 shares during the last quarter. Richwood Investment Advisors LLC grew its holdings in UnitedHealth Group by 0.4% during the 4th quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate’s stock worth $2,654,000 after acquiring an additional 20 shares during the period. Global Wealth Strategies & Associates lifted its stake in shares of UnitedHealth Group by 28.6% in the 1st quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate’s stock valued at $47,000 after purchasing an additional 20 shares during the period. 44 Wealth Management LLC grew its stake in shares of UnitedHealth Group by 1.6% during the fourth quarter. 44 Wealth Management LLC now owns 1,309 shares of the healthcare conglomerate’s stock worth $662,000 after purchasing an additional 21 shares during the period. Finally, Prentice Wealth Management LLC lifted its stake in UnitedHealth Group by 0.8% in the fourth quarter. Prentice Wealth Management LLC now owns 2,527 shares of the healthcare conglomerate’s stock valued at $1,278,000 after buying an additional 21 shares during the period. 87.86% of the stock is currently owned by institutional investors.

Insider Transactions at UnitedHealth Group

In related news, Director Kristen Gil acquired 3,700 shares of the business’s stock in a transaction on Thursday, May 15th. The stock was purchased at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the transaction, the director now directly owns 3,818 shares of the company’s stock, valued at approximately $1,035,327.06. The trade was a 3,135.59% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Timothy Patrick Flynn bought 1,533 shares of the stock in a transaction dated Wednesday, May 14th. The shares were purchased at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the purchase, the director now owns 6,033 shares of the company’s stock, valued at $1,935,386.40. This trade represents a 34.07% increase in their position. The disclosure for this purchase can be found here. In the last three months, insiders acquired 109,408 shares of company stock worth $31,607,768. 0.28% of the stock is owned by company insiders.

UnitedHealth Group Price Performance

NYSE:UNH opened at $307.84 on Tuesday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The stock’s 50-day simple moving average is $381.74 and its 200 day simple moving average is $470.20. The company has a market cap of $279.25 billion, a P/E ratio of 19.86, a P/E/G ratio of 1.37 and a beta of 0.44. UnitedHealth Group Incorporated has a 52-week low of $248.88 and a 52-week high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same quarter in the previous year, the firm posted $6.91 earnings per share. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be paid a $2.21 dividend. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.10. The ex-dividend date of this dividend is Monday, June 16th. This represents a $8.84 annualized dividend and a yield of 2.87%. UnitedHealth Group’s dividend payout ratio is currently 37.02%.

Analyst Upgrades and Downgrades

UNH has been the topic of a number of analyst reports. Argus downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Monday, April 21st. Raymond James cut shares of UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a research report on Wednesday, May 14th. Oppenheimer reduced their target price on UnitedHealth Group from $600.00 to $400.00 and set an “outperform” rating on the stock in a report on Wednesday, May 14th. JPMorgan Chase & Co. dropped their price target on UnitedHealth Group from $525.00 to $405.00 and set an “overweight” rating on the stock in a research report on Thursday, May 15th. Finally, TD Securities reissued a “hold” rating and set a $308.00 target price (down from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have issued a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $426.52.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.